PMID- 17462572 OWN - NLM STAT- MEDLINE DCOM- 20071220 LR - 20211203 IS - 1074-5521 (Print) IS - 1074-5521 (Linking) VI - 14 IP - 4 DP - 2007 Apr TI - Identification of a small-molecule inhibitor of class Ia PI3Ks with cell-based screening. PG - 371-7 AB - The mammalian target of rapamycin (mTOR) signaling network is central to the regulation of cell growth in response to both growth factors and nutrients. We developed a high-throughput, cell-based assay to identify small-molecule modulators of the mTOR signaling network. One such compound, which we name quinostatin, potently inhibits this network by directly targeting the lipid-kinase activity of the catalytic subunits of class Ia PI3Ks. This study illustrates the power of unbiased, phenotypic screening as a means for illuminating cell circuitry, and resulted in the identification of a chemotype for selective inhibition of the class Ia PI3Ks. FAU - Yang, Jiong AU - Yang J AD - Howard Hughes Medical Institute, Broad Institute of Harvard and Massachusetts Institute of Technology, 7 Cambridge Center, Cambridge, MA 02142, USA. FAU - Shamji, Alykhan AU - Shamji A FAU - Matchacheep, Sirinya AU - Matchacheep S FAU - Schreiber, Stuart L AU - Schreiber SL LA - eng GR - GM38627/GM/NIGMS NIH HHS/United States GR - N01-CO-12400/CO/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PL - United States TA - Chem Biol JT - Chemistry & biology JID - 9500160 RN - 0 (Heterocyclic Compounds, 3-Ring) RN - 0 (Phosphoinositide-3 Kinase Inhibitors) RN - 0 (Quinolines) RN - 0 (Ribosomal Protein S6) RN - 0 (quinostatin) RN - EC 2.7.- (Protein Kinases) RN - EC 2.7.1.1 (MTOR protein, human) RN - EC 2.7.11.1 (Ribosomal Protein S6 Kinases, 70-kDa) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) SB - IM MH - Catalytic Domain MH - Cell Line, Tumor MH - Heterocyclic Compounds, 3-Ring/chemistry/*isolation & purification/*pharmacology MH - Humans MH - Phosphatidylinositol 3-Kinases/chemistry/metabolism MH - *Phosphoinositide-3 Kinase Inhibitors MH - Phosphorylation/drug effects MH - Protein Kinases/metabolism MH - Quinolines/chemistry/*isolation & purification/*pharmacology MH - Ribosomal Protein S6/metabolism MH - Ribosomal Protein S6 Kinases, 70-kDa/metabolism MH - Signal Transduction MH - Structure-Activity Relationship MH - TOR Serine-Threonine Kinases EDAT- 2007/04/28 09:00 MHDA- 2007/12/21 09:00 CRDT- 2007/04/28 09:00 PHST- 2006/11/28 00:00 [received] PHST- 2007/02/05 00:00 [revised] PHST- 2007/02/09 00:00 [accepted] PHST- 2007/04/28 09:00 [pubmed] PHST- 2007/12/21 09:00 [medline] PHST- 2007/04/28 09:00 [entrez] AID - S1074-5521(07)00071-3 [pii] AID - 10.1016/j.chembiol.2007.02.004 [doi] PST - ppublish SO - Chem Biol. 2007 Apr;14(4):371-7. doi: 10.1016/j.chembiol.2007.02.004.